Castleview Partners’s Cano Health, Inc. CANO Stock Holding History

Castleview Partners’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$1	–	1016
2024 Q1	$1	Hold	3	–	–	﹤0.01%	899
2023 Q4	$18	Hold	3	–	–	﹤0.01%	861
2023 Q3	$76	Hold	3	–	–	﹤0.01%	663
2023 Q2	$417	Hold	3	–	–	﹤0.01%	665
2023 Q1	$273	Hold	3	–	–	﹤0.01%	652
2022 Q4	$411	Hold	3	–	–	﹤0.01%	587
2022 Q3	$3K	Buy	+3	New	+$1.88K	﹤0.01%	517
2022 Q2	–	Sell	-3	Closed	-$1.56K	–	756
2022 Q1	$1K	Buy	+3	New	+$1.89K	﹤0.01%	689
2021 Q2	$1K	Buy	+1	New	+$1.35K	﹤0.01%	892

Other funds holding CANO

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GFPC

Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Castleview Partners's CANO Position: Q2 2024 in Review

Castleview Partners sold out of Cano Health, Inc. (CANO) in Q2 2024, closing a stake of 3 shares — an estimated $1 sold.

Castleview Partners first reported a position in CANO in Q2 2021 and held it in 9 quarters. The position peaked at $3K in Q3 2022. 3 funds tracked by Wall St. Rank hold CANO as of Q2 2024.

Castleview Partners reported no remaining Cano Health, Inc. position as of Q2 2024 after selling out during the quarter.
Castleview Partners sold 3 Cano Health, Inc. shares in Q2 2024, an estimated $1.
Castleview Partners first reported a position in Cano Health, Inc. in Q2 2021 and held it in 9 quarters.
Castleview Partners's Cano Health, Inc. position peaked at $3K in Q3 2022.
3 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.